Rachel Scrivin

Dr. Rachel Scrivin

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2025 in Sports Medicine
Verified
Journal Article
Open access
PDF file
RCRicardo J.S. Costa
Ricardo J.S. Costa
SGStephanie K. Gaskell
Stephanie K. Gaskell
KHKayla Henningsen
Kayla Henningsen
NJNikki A. Jeacocke
Nikki A. Jeacocke
IMIsabel G. Martinez
Isabel G. Martinez
PYPascale Young
Pascale Young
It is now well-established that exercise can disturb various aspects of gastrointestinal integrity and function. The pathophysiology of these perturbations, termed “exercise-induced gastrointestinal syndrome (EIGS),” can lead to exercise-associated gastrointestinal symptom (Ex-GIS) inconveniences. EIGS outcomes can impact physical performance and may lead to clinical manifestation warranting medical intervention, as well as systemic responses leading to fatality. Athlete support practitioners seek prevention and management strategies for EIGS and Ex-GIS. This current position statement aimed to critically appraise the role of EIGS and Ex-GIS prevention and management strategies to inform effective evidence-based practice and establish translational application. Intervention strategies with mostly consistent beneficial outcomes include macronutrient (i.e., carbohydrate and protein) intake and euhydration before and during exercise, dietary manipulation of fermentable oligo-, di-, and mono-saccharides and polyols (FODMAP), and gut training or feeding tolerance adjustments for the specific management of Ex-GIS from gastrointestinal functional issues. Strategies that may provide benefit and/or promising outcomes, but warrant further explorations include heat mitigating strategies and certain nutritional supplementation (i.e., prebiotics and phenols). Interventions that have reported negative outcomes included low-carbohydrate high-fat diets, probiotic supplementation, pharmaceutical administration, and feeding intolerances. Owing to individual variability in EIGS and Ex-GIS outcomes, athletes suffering from EIGS and/or support practitioners that guide athletes through managing EIGS, are encouraged to undertake gastrointestinal assessment during exercise to identify underlying causal and exacerbation factor/s, and adopt evidence-based strategies that provide individualized beneficial outcomes. In addition, abstaining from prevention and management strategies that present unclear and/or adverse outcomes is recommended.


9 November 2022 in Frontiers in Nutrition
Verified
Journal Article
Open access
RSRachel Scrivin
Rachel Scrivin
RCRicardo J. S. Costa
Ricardo J. S. Costa
Fiona PellyFiona Pelly
Fiona Pelly
DLDana Lis
Dana Lis
Gary SlaterGary Slater
Gary Slater
This exploratory study investigated endurance athletes self-reported exercise-associated gastrointestinal symptoms (Ex-GIS) and associated strategies to manage symptomology. Adult endurance athletes with a history of Ex-GIS (n = 137) participating in events ≥ 60 min completed an online validated questionnaire. Respondents included runners (55%, n = 75), triathletes (22%, n = 30), and non-running sports (23%, n = 32), participating at a recreationally competitive (37%, n = 51), recreationally non-competitive (32%, n = 44), and competitive regional/national/international (31%, n = 42) levels. Athletes identified when Ex-GIS developed most frequently either around training (AT), around competitions (AC), or equally around both training (ET) and competitions (EC). Athletes reported the severity of each symptom before, during, and after exercise. Athletes predominantly categorized Ex-GIS severity as mild (< 5/10) on a 0 (no symptoms) to 10 (extremely severe symptoms) visual analog symptomology scale. The Friedman test and post hoc analysis with Wilcoxon signed rank test was conducted with a Bonferroni correction applied to determine differences between repeated measures. The only severe symptom of significance was the urge to defecate during training in the ET group (Z = –0.536, p = 0.01). Ex-GIS incidence was significantly higher during training and competitions in all categories. A content review of self-reported strategies (n = 277) to reduce Ex-GIS indicated popular dietary strategies were dietary fiber reduction (15.2%, n = 42), dairy avoidance (5.8%, n = 16), and a low fermentable oligosaccharides, monosaccharides, and polyols (FODMAP) diet (5.4%, n = 15). In contrast, non-dietary strategies included the use of medications (4.7%, n = 13) and relaxation/meditation (4.0%, n = 11). On a Likert scale of 1–5, the most successful dietary strategies implemented were dietary fiber reduction (median = 4, IQR = 4, 5), low FODMAP diets (median = 4, IQR = 4, 5), dairy-free diets (median = 4, IQR = 4, 5), and increasing carbohydrates (median = 4, IQR = 3, 4). Accredited practicing dietitians were rated as the most important sources of information for Ex-GIS management (n = 29). Endurance athletes use a variety of strategies to manage their Ex-GIS, with dietary manipulation being the most common.

1 June 2024 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
RSRachel Scrivin
Rachel Scrivin
Gary SlaterGary Slater
Gary Slater
AMAlice Mika
Alice Mika
CRChristopher Rauch
Christopher Rauch
PYPascale Young
Pascale Young
RCRicardo J.S. Costa
Ricardo J.S. Costa
This study investigated the effects of a high carbohydrate diet, with varied fermentable oligo-, di-, and mono-saccharide and polyol (FODMAP) content, before endurance exercise on gastrointestinal integrity, motility, and symptoms; and subsequent exercise performance. Twelve endurance athletes were provided with a 48 h high carbohydrate (mean ± SD: 12.1 ± 1.8 g kg day −1 ) diet on two separate occasions, composed of high (54.8 ± 10.5 g day −1 ) and low FODMAP (3.0 ± 0.2 g day −1 ) content. Thereafter, participants completed a 2 h steady-state running exercise at 60% of [ ] (22.9 ± 1.2 °C, 46.4 ± 7.9% RH), followed by a 1 h distance performance test. Pre-exercise and every 20 min during steady-state exercise, 100 mL maltodextrin (10% w/ v) solution was consumed. A 150 mL lactulose (20 g) solution was consumed 30 min into the distance performance test to determine orocecal transit time (OCTT) during exercise. Blood was collected pre- and post exercise to determine gastrointestinal integrity biomarkers (i.e., I-FABP, sCD14, and CRP). Breath hydrogen (H 2 ) and gastrointestinal symptoms (GIS) were determined pre-exercise, every 15 min, during and throughout recovery. No differences in gastrointestinal integrity biomarkers, OCTT, or distance completed were observed between trials. Pre-exercise total-GIS (1.3 ± 2.9 vs. 4.3 ± 4.4), gut discomfort (9.9 ± 8.1 vs. 15.8 ± 9.0), and upper-GIS (2.8 ± 2.6 vs. 5.7 ± 4.8) during exercise were less severe on high carbohydrate low FODMAP (HC-LFOD) versus high carbohydrate high FODMAP (HC-HFOD) ( p < 0.05). Gut discomfort (3.4 ± 4.4 vs. 0.2 ± 0.6) and total-GIS (4.9 ± 6.8 vs. 0.2 ± 0.6) were higher during recovery on HC-LFOD versus HC-HFOD ( p < 0.05). The FODMAP content of a 48 h high carbohydrate diet does not impact gastrointestinal integrity or motility in response to endurance exercise. However, a high FODMAP content exacerbates GIS before and during exercise, but this does not impact performance outcomes.

12 April 2023 in Frontiers in Nutrition
Verified
Journal Article
Open access
RSRachel Scrivin
Rachel Scrivin
RCRicardo J. S. Costa
Ricardo J. S. Costa
Fiona PellyFiona Pelly
Fiona Pelly
DLDana Lis
Dana Lis
Gary SlaterGary Slater
Gary Slater
This study aimed to explore carbohydrate (CHO) knowledge, beliefs, and intended practices of endurance athletes who experience exercise-associated gastrointestinal symptoms (Ex-GIS) compared to those without Ex-GIS. A validated online questionnaire was completed by endurance athletes (n = 201) participating in >60 min of exercise that present with Ex-GIS (n = 137) or without (n = 64). Descriptive statistics were used for parametric and non-parametric data with appropriate significance tests. Associations between categorical data were assessed by Chi-square analysis, and post-hoc Bonferroni tests were applied when significant. A content analysis of open-ended responses was grouped into themes, and quantitative statistics were applied. Participants included runners (n = 114, 57%), triathletes (n = 43, 21%) and non-running sports (n = 44, 21%) who participate in recreational competitive (n = 74, 37%), recreational non-competitive (n = 64, 32%), or competitive regional, national, or international levels (n = 63, 31%). Athletes correctly categorized CHO (x̄ = 92–95%) and non-CHO (x̄ = 88–90%) food and drink sources. On a Likert scale of 1 (strongly disagree) to 5 (strongly agree) athletes typically agree or strongly agree that consuming CHO around key training sessions and competitions enhances athletic performance [median = 4 (IQR, 4–5)], and they intend to consume more CHO around exercise [median = 3 (IQR, 2–3)]. No differences in beliefs and intentions were found among athletes with or without Ex-GIS. To enhance athletic performance, most endurance athletes intend to consume more CHO around exercise. Adequate knowledge of CHO-containing food sources was apparent; however, specific CHO ingestion practices remain to be verified.

1 July 2025 in International Journal of Sport Nutrition and Exercise Metabolism
Verified
Journal Article
Closed access
PDF file
RSRachel Scrivin
Rachel Scrivin
Gary SlaterGary Slater
Gary Slater
RCRicardo J.S. Costa
Ricardo J.S. Costa
This case-series describes a four-phase management approach implementing gastrointestinal assessment during exercise (GastroAxEx) to develop therapeutic interventions for athletes affected by exercise-associated gastrointestinal symptoms (Ex-GIS). Recreational to elite-level athletes who experienced recurrent severe Ex-GIS (n = 9) and controls (n = 2) (without Ex-GIS) volunteered to participate in the case series. The four-phased approach involved a clinical assessment (Phase 1), a standardized laboratory GastroAxEx where physiological strain and GIS data were collected (Phase 2), individualized therapeutic intervention and management strategies based on Phase 2 outcomes that specifically included implementation of a 48-hr high carbohydrate low FODMAP diet (Phase 3), and the monitoring and adjustment of therapeutic interventions (Phase 4). The majority of athletes (n = 6/9) consumed <400 ml/hr of fluid ad libitum, resulting in 2%–4% body mass loss, and <40 g/hr of exogenous carbohydrate (n = 8/9), during the GastroAxEx. Severe Ex-GIS (predominantly loose stools) was reported by n = 4/9 athletes, whereas n = 8/9 athletes reported severe Ex-GIS (predominantly loose stools) in the recovery period. All athletes reported low food and fluid intake tolerance during exercise and recovery. Orocecal transit time was slow or delayed for n = 2/9 athletes. Most athletes (n = 8/9) successfully implemented a 48-hr high carbohydrate low FODMAP prior to and improved intake tolerance during the targeted event. In addition, the incidence and severity of Ex-GIS were reduced, resulting in improved perceived work output during the targeted events. A 48-hr high carbohydrate low FODMAP before endurance exercise appears to be a valuable addition to suggested therapeutic interventions used to mitigate Ex-GIS.